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Background: C. elegans mitochondrial (Mit) mutants have disrupted mitochondrial electron transport chain
function, yet, surprisingly, they are often long-lived, a property that has offered unique insights into the molecular
mechanisms of aging. In this study, we examine the phenotypic consequences of reducing the expression of the
respiratory chain complex assembly factors sft-1 (homologous to human SURF1) and oxa-1 (homologous to human
OXA1) by RNA interference (RNAi). Mutations in human SURF1 are associated with Leigh syndrome, a
neurodegenerative condition of the brain caused by cytochrome oxidase (COX) deficiency. Both SURF1 and OXA1
are integral proteins of the inner mitochondrial membrane, functioning in the COX assembly pathway.
Results: RNAi of both of these genes in C. elegans is associated with increased longevity, but the mechanism by
which lifespan is extended is different in each case. sft-1(RNAi) animals display lifespan extension that is dependent
on the daf-16 insulin-like signaling pathway, and associated with sensitivity to oxidative stress. oxa-1(RNAi) animals,
in contrast, exhibit increased longevity that is at least partially independent of daf-16, and associated with a
reduced developmental rate and increased resistance to oxidative stress.
Conclusions: This study further delineates the consequences of mitochondrial dysfunction within a whole
organism that will ultimately help provide new models for human mitochondrial-associated diseases. The difference
in phenotype observed upon down-regulation of these two COX assembly factors, as well as phenotypic
differences between these factors and other respiratory chain components analyzed thus far, illustrates the complex
inter-relationships that exist among energy metabolism, reproduction and aging even in this simplest of metazoan
model organisms.
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Defects in mitochondrial function are implicated in a
wide range of human diseases, affecting both develop-
ment and the maintenance of normal structure and
function [1]. The complexes of the mitochondrial re-
spiratory chain are each composed of multiple subunits
derived from both nuclear and mitochondrial genes. Be-
cause of the dual genetic contributions, it has proved
difficult to generate model systems in which to study the* Correspondence: alison.woollard@bioch.ox.ac.uk
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reproduction in any medium, provided the orconsequences of specific mitochondrial defects, particu-
larly those due to primary mutations in mitochondrial
DNA (mtDNA). One way to approach this problem is to
exploit the observations that a number of accessory pro-
teins are required for the assembly of respiratory chain
complexes in the inner mitochondrial membrane [2-4].
Deficiencies of these complexes, either singly or in com-
bination, can be generated by targeted disruption of the
nuclear genes for these assembly factors. In addition, de-
fects in the assembly proteins often do not result in
complete deficiency of the respiratory complexes and
this is an advantage when studying key components of
the main energy generating system of the cell, where. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lethality.
The nematode worm, C. elegans is an established
model organism for the study of pathogenesis of human
mitochondrial diseases, exploiting the remarkable degree
of evolutionary homology between both nuclear-encoded
and mtDNA-encoded components of complexes of the re-
spiratory chain, as well as associated assembly factors
(reviewed in [5,6]. There are a number of reports of the
consequences of defects in mitochondrial function in C.
elegans (reviewed in [7,8]. These studies were often under-
taken in the first instance to evaluate C. elegans as a
potential model system for the investigation of pathogenic
mechanisms in human mitochondrial disease; however,
some unexpected phenotypic consequences of mitochon-
drial enzyme deficiencies were soon identified, particularly
in relation to lifespan. While these are not immediately
relevant to the human diseases, they may provide unique
insights into the molecular mechanisms of aging [8,9].
One of the most striking findings is that different
mitochondrial defects, which result in comparable levels
of impairment of energy generation, can have opposite
effects on lifespan. For example, mutation in the isp-1
gene, encoding a Reiske iron sulphur protein that is a
component of mitochondrial complex III, displays de-
creased mitochondrial respiration and significantly
prolonged lifespan [10]. Likewise, clk-1 mutants, lacking
an enzyme required for ubiquinone synthesis (essential
for complex I-dependent respiration), lrs-2 mutants
(lacking a mitochondrial tRNA synthetase), and nuo-1
and atp-2 mutants, containing defects in mitochondrial
proteins affecting complexes I and V, respectively, all
display an increased lifespan [11-13]. Furthermore, vari-
ous genome-wide RNAi screens have identified a wide
range of mitochondrial genes that, when silenced, pro-
long lifespan [10,12,14,15].
In contrast, the complex I subunit mutant gas-1
(fc210), has a shortened lifespan [16], as has the complex
II subunit mutant mev-1(kn1) and the complex III sub-
unit mutant ucr-2.3(pk732) [9,17]. Thus, there is no sim-
ple relationship between the respiratory chain complex
targeted and the phenotypic outcome. An early assump-
tion in the field, based on the “free radical theory of age-
ing” was that oxidative stress would play a key role in
the altered longevity of mitochondrial mutants, with im-
paired mitochondrial function lowering the level of re-
active oxygen species (ROS) and, hence, increasing
lifespan. Alternatively, interfering with the function of
respiratory chain complexes can in some situations lead
to increased ROS and, therefore, shorten lifespan. How-
ever, extensive investigations have collectively revealed
that oxidative damage can be experimentally dissociated
from aging (reviewed in [8]). For example, slow physio-
logical rates and prolonged lifespan were not found tobe associated with increased stress resistance or reduced
oxidative damage in Clk mutants that displayed mito-
chondrial dysfunction and evidence of decreased energy
utilization [18]. Furthermore, oxidative stress was shown
to actually increase worm lifespan in particular experi-
mental conditions [19-22] and it has been proposed that
increased ROS levels can lengthen lifespan via increased
HIF-1 activity (reviewed in [23]), or by signaling to other
endogenous defense mechanisms as part of an adaptive
response (reviewed in [24]. Thus, it will be necessary to
compare the functions of many different mitochondrial
components, identifying common and conflicting fea-
tures, to determine key elements in the relationship be-
tween mitochondria and aging.
In this study, we compare the consequences of the
deficiency of two mitochondrial respiratory chain assem-
bly factors, the protein products of the sft-1 and oxa-1
genes. Targeted silencing of these C. elegans genes by
RNA interference (RNAi) produces model deficiencies of
these proteins in a tractable system, where the pheno-
typic consequences can be easily defined. The gene sft-1
is the C. elegans ortholog of the human SURF1 gene.
Mutations in SURF1 result in a systemic cytochrome
oxidase deficiency; however, the mutant phenotype is re-
stricted to the brain. Patients typically present with
Leigh syndrome, a subacute neurodegenerative condi-
tion with characteristic necrotic lesions of the basal
ganglia and brain stem [3,25]. The SURF1 gene prod-
uct is an integral protein of the inner mitochondrial
membrane, part of a 250 kDa complex which appears
to act early in the COX assembly pathway [26].
Patients with SURF1p deficiency do have some re-
sidual COX activity (5 to 10%) indicating that some
complex assembly can occur in the absence of this
protein.
The human OXA1 and C. elegans oxa-1 genes encode
the protein OXA1, a ubiquitous component of the inner
mitochondrial membrane that inserts mitochondrially
synthesized cytochrome oxidase subunits COX1, COX2
and COX3 into the inner membrane co-translationally,
via binding of its C-terminal domain to the mitochon-
drial ribosome [27]. Human OXA1 deficiency may be
embryonic lethal, as no patients have yet been described.
Although both SURF1/SFT-1 and OXA-1 are compo-
nents of the inner mitochondrial membrane that func-
tion in the assembly of respiratory chain complexes, the
consequences of sft-1 and oxa-1 knockdown in C.
elegans are quite different. The overall result of knock-
down of either gene is increased lifespan, but the mech-
anism by which prolonged lifespan is conferred, in terms
of resistance to oxidative stress and dependence on the
DAF-16/FoxO insulin-like signaling pathway compo-
nent, are different, suggesting that distinct molecular
pathways are involved.
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Decreased brood size in sft-1(RNAi) and oxa-1(RNAi)
worms
sft-1 (gene H06I04.2) and oxa-1 (gene C01A2.3) were
identified as the closest C. elegans homologues of human
SURF1 and OXA1L, respectively. sft-1 and SURF1 both
contain a Surfeit Locus 1 domain of approximately 300
amino acids, displaying 34.1% identity (53.8% similarity).
In C. elegans, sft-1 is represented by the single deletion
allele ok2277. Human and C. elegans oxa1 genes both
contain a 60 kDa inner membrane protein domain of ap-
proximately 200 amino acids, displaying 21% identity
(43% similarity). RNAi of sft-1 or oxa-1 leads to signifi-
cantly reduced gene expression and consequent reduc-
tion in cytochrome oxidase activity as assayed in whole
animals in the case of sft-1 RNAi (Figure 1A,B). Knock-
down of either gene was associated with decreased
brood size (a 27% decrease, on average, following sft-1
RNAi by injection, and a 57% decrease, on average, in
worms injected with oxa-1 dsRNA, Figure 1C). Although
similar phenotypes were observed when RNAi by feed-
ing was performed, the penetrance of defects in the lat-
ter case was slightly lower (a 15% reduction in the case
of sft-1 feeding RNAi and a 43% reduction in the case of
oxa-1 feeding RNAi). In subsequent experiments, RNAi
by injection was utilized as the more reliable method of
choice.
sft-1(RNAi) animals developed at the same rate as WT
N2 controls and did not exhibit embryonic lethality to
any significant level, suggesting that the reduction in
brood size is a consequence of reduced germ cell pro-
duction. A similar reduction in brood size was noted for
the F1 progeny of worms injected with sft-1 dsRNA as
for the injected mothers themselves. F2 progeny of
injected mothers, as expected, had normal brood sizes
(data not shown). The brood size of sft-1(RNAi) animals
could be increased if F1 progeny from sft-1 RNAi
injected worms (at the L4 stage) were mated with WT
males (data not shown), suggesting that defects in
spermatogenesis are partly responsible for the lower
brood size. However, supplying WT sperm did not re-
store brood sizes to normal, indicating that knockdown
of sft-1 leads to defects in both sperm and oocyte
production.
oxa-1 RNAi resulted in a high proportion of embry-
onic lethality (around 17% of the progeny of oxa-1
dsRNA injected animals, Figure 1C). Dead eggs showed
a range of defects at various stages in embryonic
development, including regions of necrotic death in
gastrulating early embryos, posterior abnormalities and
failure to elongate further than the 1.5-fold ‘comma’
stage (Figure 1D). Viable offspring of injected mothers
displayed a very pronounced slow growth (Gro) pheno-
type compared to N2 controls, taking over twice as longto reach adulthood, (for N2 controls, 100% of hatchlings
reached L4 (by the criteria of a visible vulva) after 48
hours. For oxa-1(RNAi) animals, 0% of hatchlings
reached L4 by 48 or 72 hours, and typically only 50% of
hatchlings reached L4 (or at least some aspects of L4)
after 96 hours). F1 progeny of oxa-1(RNAi) animals pro-
duced almost no progeny of their own.
Increased lifespan in sft-1(RNAi) and oxa-1(RNAi) worms
Cumulative survival curves of the F1 offspring of
injected sft-1(RNAi) worms show an extended lifespan
compared with the WT control (Figure 2A). Mean life-
span from L4 was 17.7 ± 0.6 days for sft-1(RNAi) worms
(n = 95) and 15.1 ± 0.5 days for N2 control (n = 79),
with 50% survival at days 19 and 15, respectively and
maximal lifespans of 27 days for sft-1(RNAi) animals and
23 days for WT (the whole data set is shown in
Additional file 1). With the F1 offspring of injected oxa-
1(RNAi) worms, the lifespan was extended even further
with a mean of 19.3 ± 0.8 days (n = 88), a maximum of
31 days and 50% survival at Day 20 (Figure 2A,
Additional file 1). Experiments were begun with animals
at the L4 stage, although it was difficult to precisely
stage oxa-1(RNAi) animals given the developmental
delay. It is possible that further developmental delay
(that is, in progressing from L4 to adulthood) could con-
tribute to the lifespan extension, although given that
oxa-1(RNAi) animals, on average, took twice as long to
reach adulthood, the delay from L4 to adulthood would
only be expected to contribute to lifespan extension by a
maximum of one day, and observed lifespan extension
was much more pronounced than this.
To ascertain whether the lifespan extension was
dependent on the daf-16 insulin-like signaling pathway,
RNAi of sft-1 and oxa-1 by injection was performed in a
daf-16(m26) mutant background, which has previously
been shown to suppress the lifespan extension of both
daf-2(e1370) and age-1(hx546) mutants [28,29]. In a daf-
16(m26) mutant background, sft-1 RNAi resulted in
mean and maximum lifespans of 13.5 ± 0.4 days (n = 92)
and 21 days respectively, very similar to daf-16 controls
(13.6 ± 0.4 days (n = 92), maximum 19 days) (Figure 2B,
Additional file 1). This suggests that lifespan extension in
sft-1(RNAi) worms is dependent upon the daf-16 pathway,
and that sft-1 may operate upstream of daf-16 to regulate
longevity.
In the case of oxa-1 RNAi in a daf-16 mutant back-
ground, however, a different result was obtained. In this
case, lifespan was still extended following oxa-1 knock-
down, with a mean lifespan of 17.9 ± 0.7 days (n = 84)
and maximum lifespan of 31 days, not statistically differ-
ent to the data obtained when oxa-1 RNAi is performed
in a wild type background (Figure 2C, Additional file 1).







































Figure 1 sft-1 or oxa-1 RNAi results in reduced gene expression, COX staining and brood size. A: RT-PCR of oxa-1 and sft-1 to compare
mRNA levels. Lane 1, 50 bp DNA ladder. Upper panel: Lane 2, RT-PCR products from WT animals. Upper band (350 bp) corresponds to eft-2 mRNA
(internal control), lower band (220 bp) corresponds to sft-1 mRNA. Lane 3, RT-PCR products from the progeny of animals injected with sft-1
dsRNA. sft-1 expression is greatly reduced. Lower panel: Lane 2, RT-PCR products from WT animals. Upper band (350 bp) corresponds to the eft-2
internal control, lower band (164 bp) corresponds to oxa-1 mRNA. Lane 3, RT-PCR products from the progeny of animals injected with oxa-1
dsRNA. oxa-1 expression is greatly reduced. B: COX staining in WT and sft-1(RNAi) animals. In WT, COX staining is particularly prevalent in the
pharynx (black arrowhead) and germ line (black arrow), tissues that have high energy demands. In sft-1(RNAi) animals, COX staining is greatly
reduced (photomicrographs taken using identical exposure times), especially in the germ line (dotted arrow). Scale bar, 100 μm. C: Brood size of
WT animals injected with sft-1 or oxa-1 dsRNA compared with control animals injected with TE only (labeled N2). Both sft-1 and oxa-1 RNAi result
in a significantly reduced brood size compared with controls (*P <0.005). The darker shaded area of the bar corresponding to oxa-1(RNAi)
represents the proportion of dead embryos. Error bars denote the standard error of the mean (SEM). D: Embryonic lethality induced by oxa-1
RNAi. Left hand panel: oxa-1(RNAi) embryos, right hand panel: WT embryos at equivalent stages. Defects can be seen throughout embryogenesis,
including necrotic regions in early embryos (i, white arrowhead), morphological defects at the “bean” stage (ii), elongation defects at the
“comma” stage (iii) and later (iv, v). Posterior defects are particularly pronounced.








































































Figure 2 Lifespan extension in sft-1(RNAi) and oxa-1(RNAi) animals. A: Lifespan curves for N2, oxa-1(RNAi) and sft-1(RNAi) animals (recorded
as number of days of survival post L4, or the time at which controls reached L4, in the case of oxa-1(RNAi) animals). Lifespan is prolonged in sft-1
(RNAi) and oxa-1(RNAi) animals compared with WT controls, with oxa-1 having the greatest effect. B: Lifespan analysis of sft-1(RNAi) animals
performed in a daf-16(m26) mutant background, in which sft-1 RNAi fails to extend lifespan. C: Lifespan analysis of oxa-1(RNAi) animals performed
in a daf-16(m26) mutant background. oxa-1 RNAi still extends lifespan under these circumstances. The data presented combine three
independent data sets (the data for individual replicate experiments can be found in Additional file 1).
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naling pathway. However, we do note that the shape of
the lifespan curves is somewhat different when oxa-1
(RNAi) animals and daf-16; oxa-1(RNAi) animals are
compared, and that the 50% survival point is reduced
from 20 to 17 days, respectively. This may suggest a
somewhat complex interaction between oxa-1 and daf-
16, or that suppression is incomplete with the daf-16 al-
lele used in this analysis, and caution needs to be
exercised in the interpretation of this result. What is
clear, however, is that the two knock-downs produce dif-
ferent phenotypes in terms of embryonic lethality, broodsize and developmental delay, and respond somewhat
differently to perturbations in the daf-16 pathway, with
sft-1 showing complete dependence on functioning daf-
16 for lifespan extension, and the oxa-1(RNAi) pheno-
type being at least partially daf-16-independent.
It has previously been reported that, in the case of
genes involved in mitochondrial function, the dose of
dsRNA delivered to C. elegans in RNAi feeding experi-
ments may affect the phenotypic outcome, with lower
doses of particular dsRNAs causing lifespan extension
while higher doses shorten lifespan [9]. It is well
established that RNAi by injection tends to give more
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ments, we used undiluted dsRNA for injections, presum-
ably representing the highest possible dose of RNAi. In
addition, feeding RNAi experiments also resulted in life-
span extension (SM and AW, unpublished observations),
suggesting that in the case of sft-1 and oxa-1, the pheno-
typic outcome is unlikely to be dose-dependent (at least in
terms of different doses resulting in opposite phenotypes).
Response to oxidative stress following sft-1 and oxa-1
knockdown
To investigate whether the lifespan extension was associ-
ated with resistance to oxidative stress, sft-1(RNAi) and
oxa-1(RNAi) worms were subjected to oxidative stress
treatment with the herbicide paraquat. This causes
oxidative stress by a metabolically catalyzed reaction
resulting in depletion of NADPH and production of
ROS, primarily superoxide anions [30].
The resistance to oxidative stress of the sft-1(RNAi)



















































Hours of exposure to paraquat
Figure 3 Sensitivity of sft-1(RNAi) and oxa-1(RNAi) animals to
oxidative stress. A: Survival curves of WT or sft-1(RNAi) animals
exposed to 10 mM or 25 mM paraquat, recorded as the number of
hours of survival following exposure. WT and sft-1(RNAi) animals
display similar sensitivity to paraquat at either concentration. B:
Survival curves of size-matched WT and oxa-1(RNAi) animals exposed
to paraquat. oxa-1(RNAi) animals show marked resistance to
paraquat, at both 10 mM and 25 mM concentrations.controls at either 10 or 25 mM paraquat (Figure 3A),
with mean survival time following exposure of sft-1
(RNAi) animals to 10 mM paraquat of 61.3 ± 2 hours
(n = 36), compared to 65 ± 3.1 hours for WT controls
(n = 29). Similarly, exposure to 25 mM paraquat resulted
in a mean survival time of 35.4 ± 1.5 hours for sft-1
(RNAi) animals (n = 36) compared with 33.8 ± 1.3 hours
for WT controls (n = 35) (Additional file 2). By contrast,
the oxa-1(RNAi) worms were much more resistant to
paraquat than the control worms at both concentrations
(Figure 3B). Given the Gro phenotype of oxa-1(RNAi)
animals and, therefore, the time it takes for them to
reach L4 (when our paraquat survival assays normally
start), we used three-day-old progeny of oxa-1 dsRNA
injected hermaphrodites, and size-matched WT controls
(L1s), to control for the possibility that animal size could
have an effect on paraquat sensitivity that could compli-
cate our results. In this case, exposure to 10 mM para-
quat resulted in a mean survival time of 58.4 ± 1.9 hours
for WT (n = 38) and 100.1 ± 1.9 hours for oxa-1(RNAi)
animals (n = 42). Increasing the concentration of para-
quat to 25 mM gave similar results, with a mean survival
time of 35.9 ± 1.2 hours for WT (n = 39) and 49.7 ± 1.9
hours for oxa-1(RNAi) animals (n = 48) (whole data set
shown in Additional file 3). In the case of the oxa-1
(RNAi) animals used for this experiment, it is difficult to
categorically state what developmental stage they were
at. They were size-matched to L1 control WT animals,
but may have been more advanced in terms of certain
aspects of development, which could be uncoupled when
oxa-1 is knocked down and overall growth slows. In any
case, however, it is noteworthy that WT animals did not
appear to display any size-dependent resistance to para-
quat (mean survival time of 65 ± 3.1 hours for L4 ani-
mals following exposure to 10 mM paraquat, compared
with 58.4 ± 1.9 for L1s, and 33.8 ±1.3 hours for L4s
compared with 35.9 ± 1.2 hours for L1s exposed to 25
mM paraquat), indicating that animal size differences
are unlikely to be confounding our data.
OXA-1 and SFT-1 tissue distributions
oxa-1::GFP
The expression pattern of a translational oxa-1::gfp
fusion construct is shown in Figure 4. oxa-1::gfp is
expressed at high levels throughout the animal. oxa-1::
gfp expression is widely distributed, showing a punctate
mitochondrial network pattern, and is particularly prom-
inent in pharyngeal and body wall muscle (Figure 4).
Mitochondria form elongated filaments or networks in
many cell types that is particularly prominent in tissues
with a high energy demand, such as muscle. To demon-
strate that the expressed product did indeed localize to
mitochondria, oxa-1::gfp worms were stained with
Mitotracker Red and extensive co-localization was
AB
Figure 4 oxa-1::gfp expression pattern. A, B: Transgenic strain AW241 (ouEx609 (pAW318 + rol-6-)), where pAW318 is a translational GFP fusion
of oxa-1 driven by the endogenous promoter. oxa-1 is expressed at a high level throughout the worm in a reticular mitochondrial network
pattern characteristic of mitochondrial proteins. A: expression of oxa-1::gfp is particularly strong in body wall muscle cells, where it is excluded
from the nuclei (white arrow). B: co-localization of oxa-1::gfp (left hand green image) and Mitotracker Red (central red image) in the merged
image (right hand yellow image), confirming expression of oxa-1::gfp in mitochondrial networks. Scale bar, 100 μm. Anterior is to the left in
all images.
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very faint, but observable at the 100 cell stage (data not
shown).
sft-1::gfp
The sft-1 gene appears to be contained within a large
operon, CEOP3088, making the construction of reporter
constructs problematic, as it is difficult to predict where
the important regulatory elements will be and the
required constructs are likely to be very large
(CEOP3088 covers some 40 Kb). Recent analysis sug-
gests that sft-1 is part of a “hybrid” operon, however,
containing intercistronic promoter/enhancer elements
required for tissue-specific gene expression [31]. Given
the relatively large intercistronic region in the case of
sft-1 (>1.5 Kb), we made a translational reporter con-
struct in which this region was used to drive sft-1::gfp,
which would be expected to report on at least part of
the sft-1 expression pattern. The expression pattern
obtained with this construct is shown in Additional file 4.
sft-1::GFP is expressed at a very low level throughout the
worm with higher levels of expression in a region of body
wall muscle adjacent to the pharyngeal bulb (Additional
file 4A) and the uterine area (Additional file 4B). The low
overall level of expression may well reflect the absence of
operon-upstream regulatory elements from the sft-1::gfp
construct.
Discussion
Cytochrome oxidase deficiency generated by RNAi of
sft-1 resulted in lifespan extension accompanied by de-
creased germ cell production but no obvious slowdown
of developmental rate, whereas the lifespan extension
caused by RNAi of oxa-1 was associated with apronounced slow growth phenotype and lethal defects in
embryonic development. The combination of dead em-
bryos and long-lived progeny in the broods of oxa-1
(RNAi) animals could reflect some mitochondrial
“threshold effect” in which the threshold for mitochon-
drial function is surpassed in some embryos, leading to
catastrophic mitochondrial damage and the inability to
invoke compensatory pathways.
The embryonic lethality and slow growth of viable
progeny observed with RNAi of oxa-1 correlates with
phenotypic observations of oxa-1 homologues in other
organisms. Inactivation of both OXA1 genes in S. pombe
is lethal [32], whereas a knockout mutant of S. cerevisiae
is viable, but is unable to respire and can only grow on
fermentable carbon sources [4]. The function of these
various OXA1 proteins is conserved, as N. crassa, hu-
man and S. pombe homologues can rescue S. cerevisiae
oxa1 null mutants [33]. In yeast, defects in Oxa1 ablate
the function of the cytochrome oxidase complex and
greatly reduce levels of Complex III and F0F1ATPase
[34]. Overall, the data suggest that OXA1 is important
for the biogenesis of several different respiratory chain
complexes (reviewed in [35]) and this may account for
the severity of the oxa-1 RNAi phenotype seen in C.
elegans. Consistent with this, no OXA1 deficient patients
have been identified and this condition may thus be em-
bryonic lethal in humans.
SURF1 deficient patients, on the other hand, usually
survive into early childhood with a progressive neurode-
generative disease. In contrast to the human SURF1 defi-
cient phenotype, no abnormal neuromuscular function
was observed in sft-1(RNAi) worms, despite detailed ob-
servations of movement and pharyngeal pumping rates
(data not shown). A possible caveat to this conclusion,
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tively ineffective in the nervous system, thus neuronal
phenotypes may have been masked in our experiments.
It is also possible that the lack of a neuromuscular
phenotype in the sft-1 deficient worms may simply re-
flect overall energy requirements and the level of energy
generation in different tissues. Previous studies of meta-
bolic activity in C. elegans, as monitored by oxygen con-
sumption, indicate that only a small proportion of total
energy expenditure is on movement and the greatest sin-
gle energetic demand is for reproduction [36]. There is a
significant increase in oxygen consumption at the L3
and L4 larval stages, the time of extensive proliferation
of germ cells (reviewed in [37]. Reflecting this depend-
ence of reproduction on energy generating capacity, mu-
tations leading to deficiency of two other components of
the mitochondrial oxidative phosphorylation system,
Complex I (nuo-1 gene) and the F1F0 ATP synthase
(atp-2 gene) also show a marked abnormality in gonadal
development [13].
Decreased fecundity of sft-1(RNAi) worms was attrib-
uted to a failure of both oogenesis and spermatogenesis,
as unfertilized oocytes were not observed at a significant
level and WT sperm was only able to partially restore
the brood size. Consistent with the hypothesis that de-
creased energy generating capacity in sft-1(RNAi) worms
due to COX deficiency may account for the reproductive
failure, we observed high levels of COX activity in the
germ line of WT animals. sft-1::gfp was not observed in
the germline, but a likely explanation for this is the
phenomenon of gene silencing that is often triggered by
transgene expression in the germline [38].
Both sft-1(RNAi) and oxa-1(RNAi) worms can be
described as having Mit phenotypes (that is, those asso-
ciated with mitochondrial dysfunction). Knockdown of
either gene resulted in a significantly extended lifespan
(particularly in the case of oxa-1) in at least two inde-
pendent experiments, while only the oxa-1(RNAi) worms
were resistant to oxidative stress induced by treatment
with paraquat. The relationship between mitochondrial
function and lifespan in C. elegans is complex, although
most observations support two contributory mecha-
nisms, nutritional restriction and damage due to ROS.
Many different observations link nutritional/energetic
status and lifespan in a wide range of different species.
Food deprivation, either environmental or genetically
determined (for example, eat-2 gene mutations [39]) and
mutations in genes involved directly (for example, nuo-1
[13]) or indirectly (for example, clk-1 [40]) in mitochon-
drial energy metabolism have all been shown to prolong
life in C. elegans. These observations are incorporated in
the “rate of living model” for longevity in which in-
creased life expectancy is attributed to a generalized
slowing down of metabolic function.In nearly all cases examined thus far, lifespan exten-
sion in Mit mutants has been shown to act independ-
ently of the insulin/IGF signaling pathway [5]. Therefore,
the dependence of sft-1(RNAi) animals on daf-16 for
lifespan extension, suggesting that sft-1 may act up-
stream of daf-16 to regulate longevity, is noteworthy,
putting sft-1 knockdown in a different phenotypic cat-
egory from most other Mit phenotypes. The FoxO-like
forkhead/winged helix transcription factor DAF-16 is
thought to be a master regulator of aging, integrating
metabolic signals, stress signals as well as reproductive
signals from the germline to modulate longevity [41].
Perhaps the dependence of lifespan extension in sft-1
(RNAi) animals on daf-16 reflects the relative import-
ance of reduced fecundity in promoting longevity when
sft-1 expression is reduced.
The second model for the determination of lifespan in
C. elegans is based on the accumulation of damage due
to ROS, although recent analyses suggest a rather com-
plex relationship between oxidative stress and aging, and
one that can be experimentally uncoupled. The oxidative
damage model is not independent of the rate of living
model as the major site for the formation of ROS is the
mitochondrion and production is related to the level of
metabolic activity. Some Mit mutants (for example, lrs-2
and isp-1), in common with IGF/insulin signaling path-
way mutants daf-2 and age-1, show increased lifespan
and resistance to oxidative stress [12], reviewed in [8].
oxa-1, as presented here, appears to fall into this cat-
egory. By contrast, gas-1, nuo-1 and mev-1 mutations
confer reduced lifespan associated with a hypersensitivity
to free radicals [16,42,43], reviewed in [8]. Resistance to
oxidative stress is suggested to extend lifespan by de-
creasing damage caused by accumulation of free radicals
in the cell.
On the other hand, mutants such as clk-1 and sod-2 dis-
play a hypersensitivity to oxidative stress but are also long-
lived [18,22], suggesting that oxidative stress per se is not
always a primary cause of aging. Indeed, it has been
suggested that ROS generated inappropriately in some
mitochondrial mutants might actually extend lifespan by
signaling various adaptive responses [12,44]. This pro-
posed preconditioning of mitochondria has been termed
mitohormesis [45]. Intriguingly, though, there do not ap-
pear to be mutants that are highly resistant to oxidative
stress yet display a shortened lifespan, supporting the idea
that oxidative stress resistance (or adaptation to oxidative
stress) is associated with a long life.
“Oxidative stress resistance” is rather an umbrella
term, as different Mit mutants display different sensitiv-
ities to a spectrum of oxidative stresses. For example, in
one study of 10 different mutant/RNAi strains, most of
the long-lived worms with compromised mitochondria
displayed marked resistance to hydrogen peroxide, yet
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ity) to paraquat [12]. The authors of this study proposed
that as paraquat triggers the production of superoxide in
a NADPH-dependent reaction, paraquat hypersensitivity
of worms with mitochondrial dysfunction might be due
to an increase in NADPH associated with a particular
metabolic response to reduced electron transport. How-
ever, the data that we present here indicate that oxa-1
(RNAi) worms, in contrast to those analyzed in the Lee
study, exhibit marked resistance to paraquat. This sug-
gests that it is very difficult to generalize about the ef-
fects of mitochondrial dysfunction, even within the
group of mutants/RNAi-treated worms that display both
prolonged lifespan and heightened stress resistance. Fur-
thermore, a recent study has found that pathways of life-
span extension can differ depending on whether RNAi
or mutation for the same gene is used to reduce gene
function [46]. Mutations in sft-1 or oxa-1 were not ana-
lyzed here, but these would form an interesting subject
for future analysis.
It has been previously suggested that long-lived Mit
mutants utilize a novel metabolism, and that longevity
in these animals may be dependent on this altered meta-
bolic state. For example, it has been proposed, albeit
using a limited number of mutants, that long-lived Mit
mutants up-regulate fermentative malate dismutation,
where fumarate is terminally reduced at complex II to
succinate, generating fewer radical species overall [17].
This is an anaerobic metabolic pathway thought to be
unique to nematodes, and normally up-regulated dur-
ing dauer formation. However, other studies argue that
although metabolic restructuring does indeed occur in
Mit mutants, the restructuring per se does not cause
lifespan extension [47]. Recent data, however, chal-
lenge this view. For example, the importance of the
alternative glyoxylate pathway in Mit mutant lifespan
extension has been investigated by knocking down
gei-7, which encodes the main glyoxylate shunt en-
zyme in C. elegans. gei-7 mutation was found to sup-
press the enhanced longevity of clk-1 mutants [48] and
has also been found to reduce the lifespan of cyc-1 Mit
mutants [49].
Strikingly, mitochondrial respiratory complex dysfunc-
tion models being developed in other systems display
many of the same features as C. elegans Mit mutants.
For example, a partial deficiency of Mclk1, the mouse
clk-1 ortholog, increases average lifespan by 30% [50].
Even more relevant to this study, increased lifespan fol-
lowing inactivation of Surf1 in mice has been recently
demonstrated [51], and similarly, Surf1 knockdown in
the central nervous system of Drosophila melanogaster
has also been shown to induce longevity [52]. This sug-
gests that the function of sft-1 in regulating lifespan is
likely to be widely conserved, and it will be veryinteresting to discover the extent to which precise mech-
anisms of lifespan extension are conserved between dis-
parate species. For example, it would be interesting to
examine whether lifespan extension in sft-1 knockdown
animals is dependent on gei-7 and thus a shift to the
glyoxylate pathway. It is not clear, however, how such
metabolic restructuring might proceed in other organ-
isms where this alternative pathway is not thought to
operate.
Whatever the precise mechanisms, it is clear that sft-1
and oxa-1 influence longevity through distinct molecular
pathways, despite the fact that both genes encode factors
required for COX assembly.
Conclusions
We have clearly shown that knockdown of sft-1 or oxa-1
by RNAi results in increased longevity; however, distinct
molecular mechanisms appear to operate in each case,
and analysis of these two genes illustrate the principle that
it is not possible to draw simple conclusions about the re-
lationships between mitochondrial energetics, longevity,
stress resistance and insulin-like signaling. Further analysis
of COX deficiency and generation of worms with defects
in other mitochondrial enzyme complexes will be required
to further delineate the organismal consequences of mito-
chondrial dysfunction that will help provide new models
for human mitochondrial-associated diseases. For the
present, analysis of the effects of reducing expression of
sft-1 and oxa-1, both of which encode proteins required
for the assembly of respiratory complexes, illustrates the
diversity of phenotypic outcomes that can result from
mitochondrial dysfunction and the complex inter-
relationships that exist between energy metabolism,
reproduction and aging even in this simplest of metazoan
model organisms.
Methods
C. elegans strains and maintenance
Experiments were performed with the wild-type (WT)
Bristol strain N2 and daf-16(m26) mutant (provided by
the Caenorhabditis Genetics Center). C. elegans strains
were maintained and handled on nematode growth
media (NGM) agar with E. coli OP50 as their food
source [52]. Microscopy was carried out using a Zeiss
Axiophot microscope (Carl Zeiss Ltd, Bicester, Oxon,
UK) fitted with DIC and fluorescence optics as appropri-
ate. Worms were anesthetized on 2% agarose pads as
previously described [53].
Bioinformatic analysis
Homologs were identified by BLAST analysis (http://blast.
ncbi.nlm.nih.gov). C. elegans protein sequences were
retrieved from Wormbase (www.wormbase.org) and
human protein sequences from the Ensembl database
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wise alignment in Bioedit (www.mbio.ncsu.edu/bioedit/
bioedit.html).
RNAi by injection
PCR primers specific for sft-1 (C. elegans gene H06I04.2)
and oxa-1 (C01A2.3) and including T7 or T3 RNA poly-
merase promoter sites were designed. These amplified
fragments of 679 bp and 515 bp were from genomic
DNA, respectively.
sft-1 F primer 5’ ATTAACCCTCACTAAAGTTATT
TTGAAGC 3’ JH1;
sft-1 R primer 5’AATACGACTCACTATAGGTGACG
GGGAATTC 3’ JH2
oxa-1 F primer 5’ATTAACCCTCACTAAAGACA
TTCCCTGGTGGGTTACA 3’ JH5.
oxa-1 R primer 5’AATACGACTCACTATAGACGCA
TAATTGGTGGCATTT 3’ JH6
dsRNA was synthesized directly from PCR products as
previously described [54] and injected into young adult
hermaphrodites as previously described [55]. Injected
worms were transferred to fresh seeded plates four hours
after injection and the progeny assayed for relevant phe-
notypes, except in the case of brood size measurements,
which were performed on the injected mothers them-
selves as well as the subsequent F1 progeny.
RNAi by feeding
L3 N2 (or daf-16(m26)) hermaphrodites were picked
onto IPTG plates which had been seeded with the rele-
vant bacterial RNAi feeding clones as previously de-
scribed [56]. The oxa-1 feeding clone in the feeding
RNAi bacterial strain HT115 was from the Ahringer Lab
RNAi feeding library [57]. The sft-1 feeding clone was
made by inserting a PCR fragment corresponding to 400
bp of sft-1 exonic sequence (amplified from fosmid
H06104) into the L4440 RNAi feeding vector, using en-
zymes XbaI and HindIIII. This was electroporated into
E. coli strain HT115 before feeding to worms.
RT-PCR
Reduction of the target transcripts following RNAi treat-
ment was confirmed by gene-specific RT-PCR using the
Superscript III RT system (Life Technologies (Invitrogen
Division). Renfrew, Paisley, UK) with RNA from 20 L4
progeny from sft-1(RNAi) worms and six plates of pro-
geny from oxa-1(RNAi) worms and equivalent N2 con-
trols. Transcript levels of a non-target gene, eft-2, were
measured as a control for the specificity of the RNAi.
The RT reaction was primed using oligo(dT) primers.
RNA was extracted using a hot phenol protocol [58] and
purified using a DNAse column. A total of 5 μL of RNA
dissolved in RNAse free water was used in the RT reac-
tion to synthesize cDNA.Specific sft-1, oxa-1and eft-2 RT-PCR primers were
designed and amplified 220 bp, 164 bp and 350 bp frag-
ments, respectively. Twenty-five cycles of PCR were
used in each case.
sft-1 F primer 5’ GAAAGGGCGACTGAATCAAA 3’ JH7
sft-1 R primer 5’ GTGTCCTCCATGACTGCTCA 3’ JH8
oxa-1 F primer 5’ GCACTTCCATTCATCTCTGC 3’ JH9
oxa-1 R primer 5’ CATAGACCCGTAGCAAATTGTG
3’ JH10
eft-2 F primer 5’ GCGTATCAAGCCAGTTCTTT 3’
JH19
eft-2 R primer 5’ CTGCTCCACTTCTTGGTCTT 3’
JH20
Brood counts
Brood sizes were assessed using 20 synchronized L4
worms each injected with dsRNA corresponding to sft-1
or oxa-1. Control groups were injected with TE buffer
only. (In the case of feeding RNAi experiments, L3 ani-
mals were first picked onto NGM plates seeded with
HT115 bacteria transformed with the relevant feeding
RNAi clone or empty vector control). For the brood size
counts, L4 animals were picked singly onto individual 55
mm NGM plates seeded with OP50 bacteria (or HT115
transformed with the relevant feeding RNAi clone or
empty vector control), and transferred to fresh seeded
plates every 24 hours until egg laying had stopped.
Counting of unhatched eggs and live progeny was
performed on plates from which the mother had been
moved the previous day and individual plate counts to-
taled in order to derive a complete brood size for each
animal. All plates were kept at 20°C.
Cytochrome oxidase (COX) staining
COX activity was assayed in cells of intact worms by the
oxidation of diaminobenzidine in the presence of cyto-
chrome c in a protocol adapted from Seligman et al. [59].
The specificity of the COX staining reaction was demon-
strated by the absence of reaction product when worms
were incubated with sodium azide (NaN3). A total of 50
mixed-stage animals (either the progeny of animals
injected with sft-1 dsRNA, or controls) were picked into
50 μl of M9 buffer in an Eppendorf tube (in duplicate)
(Eppendorf UK Ltd, Stevenage, Herts, UK). The worms
were allowed to settle and the M9 buffer was carefully
removed. A total of 1 ml of freshly prepared COX stain
(1 mg/mL diaminobenzidine-HCl, 1 mg/mL cytochrome
c, 2 mg/mL catalase in 50 mM sodium phosphate buffer,
pH 7.4) was added to the worms and gently mixed.
Worms were incubated with the stain for 4 h at 20°C.
NaN3 was added to one of the duplicate tubes to a final
concentration of 1 mM. The COX stain was removed and
the worms gently rinsed with PBS twice. Tubes were spun
at 6,000 rpm for 8 secs to gently sediment the worms
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and allowed to air dry (approximately 30 minutes). They
were subsequently mounted for microscopy by adding a
coverslip coated with Aquatex (VWR International Ltd,
Lutterworth, Leics, UK) and samples photographed using
identical settings and exposure times. Experiments were
repeated at least three times.
Determination of lifespan
Lifespan assays were performed using 20 to 50
worms for each strain (or F1 progeny of animals that
had been injected with dsRNA corresponding to sft-1
or oxa-1, or fed on the appropriate feeding RNAi
bacteria) per experiment. Single L4 worms were
picked onto individual wells of 12-well NGM plates
seeded with OP50 bacteria, and transferred daily to
a fresh seeded well until the end of egg laying. Ani-
mals were checked for viability every day by record-
ing their response to mechanical stimulus. Worms
that did not respond to five gentle prods with a plat-
inum wire were scored as dead and the date of
death recorded. All lifespan assays were performed
at 20°C, with three biological replicates.
Sensitivity to oxidative stress
Oxidative stress sensitivity assays were performed using 50
worms for each strain (or F1 progeny of animals that had
been injected with dsRNA corresponding to sft-1 or oxa-1).
sft-1(RNAi) or oxa-1(RNAi) worms and size-matched
N2 controls were picked onto 30 mm NGM plates
(seeded with OP50 bacteria, 10 animals per plate)
containing final concentrations of 0, 10 or 25 mM para-
quat (1,1'-Dimethyl-4,4'-bipyridinium dichloride hydrate,
Sigma (Sigma-Aldrich, Poole, Dorset, UK)). Survival was
assessed at regular intervals over the course of 100 hours
by response to mechanical stimulus as described above.
Animals that escaped from the plate and thus could not
be accounted for were excluded from the analysis. All
plates were kept at 20°C.
sft-1 and oxa-1 GFP reporter constructs
sft-1 and oxa-1 translational GFP fusion constructs were
made using the PCR fusion method [60]. An 8,129 bp
fragment containing the sft-1 ORF (H06I04.2) and 3,204
bp of upstream sequence was amplified from fosmid
H06I04 using Expand Long Template polymerase
(Roche Diagnostics Ltd., Burgess Hill, West Susses, UK)
and primers JH13 and JH15. JH15 includes a tag com-
plementary to sequence at the 5’ end of GFP.
sft-1 F primer 5’GTAAGCTGGAATCGGCAAAG 3’
JH13
sft-1 R primer 5’ CGACCTGCAGGCATGCAAGCT
CCACATGAGCATTGTGAC 3’ JH15.A 6,870 bp fragment containing the oxa-1 ORF
(C01A2.3) and 3,770 bp of upstream sequence (including
all putative regulatory sequence elements within the op-
eron CE0P1696) was amplified from fosmid I6F08, using
Expand Long polymerase and primers JH16 and JH18.
JH18 includes a tag complementary to sequence at the 5’
end of GFP.
oxa-1 F primer 5’ CGTCTCTCCCATCCAGCTT 3’
JH16
oxa-1 R primer 5’ CGACCTGCAGGCATGCAA
GCATGAAGCATCACGTTGTCG 3’ JH18
To fuse the gene specific PCR products to the GFP re-
porter, 0.5 μL of each PCR product and 0.5 μL of gel
purified GFP PCR product (1.8 kb fragment, the product
of PCR with primers ppdgfp and gfp c1 from plasmid
pPD95.75 (Fire Lab vectors obtained from Addgene,
Cambridge, MA, USA) were added to the Expand Long
Buffer 3 system reaction mix to form the template for
the sewing reaction. A second forward nested primer
and GFP specific reverse primer (gfp c2) were used to
amplify the full-length gene-GFP fused PCR product.
These products were gel purified using the SYBR-RED
gel purification system.
sft-1 nested forward primer: 5’GTGTATGCAAAT
GCGACGAG 3’ JH14
oxa-1 nested forward primer 5’CGTCTCTCCCATCC
AGCTT 3’ JH17
ppdgfp primer 5’GCTTGCATGCCTGCAGGTCG3’
gfp c1 primer 5’AAGGGCCCGTACGGCCGACTAG
TAGG3’
gfp c2 primer 5’AAACAGTTATGTTTGGTATATT
GGG3’
The purified PCR products were cloned into the
TOPO XL vector using the TOPO XL cloning kit
(Invitrogen) and shown to contain the correct inserts by
restriction digest and sequencing. The sft-1::gfp con-
struct is pAW317 and the oxa-1::gfp construct is
pAW318.
Transgenic worms
GFP reporter constructs were injected into the syncytial
gonad of young adult hermaphrodite worms at a concen-
tration of approximately 20 ng/μL as described [55] along
with the rol-6- transformation marker pCes1943. Rol pro-
geny were picked and stable lines selected for analysis.
The sft-1::gfp transgenic strain described in this study is
AW240 (ouEx608 (pAW317 + rol-6-)) and the oxa-1::gfp
transgenic strain is AW241 (ouEx609 (pAW318 + rol-6-)).
Mitotracker staining
L4 stage N2 and AW241 worms were transferred to
seeded NGM plates with 2 μg/ml Mitotracker Red (Life
Technologies Ltd (Invitrogen division, Renfrew, Paisley,
UK) spread on the surface and stored in the dark. L4
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for one hour and mounted for fluorescence microscopy
as described above.
Additional files
Additional file 1: Lifespan extension in sft-1(RNAi) and oxa-1(RNAi)
worms displays differential dependence on the insulin-like
signalling pathway. A: Combined dataset for three separate
experiments. Analytical values for lifespan experiments are shown,
including mean and median adult lifespan, maximum adult lifespan and
the sample size (n) for each strain and experimental condition. Statistical
tests (Log-Rank tests using OASIS software [61]) were carried out using
the lifespan of each worm in the entire population. oxa-1(RNAi) and sft-1
(RNAi) animals have a significantly increased mean lifespan compared
with the wild type N2 strain (P = 1 x 10-7 and 2 x 10-5, respectively). daf-
16(m26); oxa-1(RNAi) animals have a significantly increased lifespan
compared with daf-16 alone (p< 1 x 10-10), but the difference is not
significant when compared with oxa-1 alone (p = 0.09). daf-16(m26); sft-1
(RNAi) animals do not have a significantly different lifespan from daf-16
alone (P = 0.75) but these animals have a significantly decreased lifespan
compared with sft-1(RNAi) alone (P < 1 x 10-10). B: Individual datasets for
the three separate experiments. Mean, median and maximum lifespans
are shown. Log-Rank tests were carried out using the lifespan of each
worm in the entire population. * denotes the significance (P) value
compared to N2 worms, ** denotes the P-value compared to daf-16(m26)
worms. oxa-1(RNAi) animals had a significant lifespan extension
compared to control animals in all three biological replicates which was
at least partially independent of daf-16. sft-1(RNAi) animals had a
significant lifespan extension compared to control animals in two out of
three biological replicates (in the third replicate the P-value was 0.079). In
all cases, the lifespan extension was dependent on daf-16 (that is,
significant lifespan extension was not observed in a daf-16(m26) mutant
background).
Additional file 2: Sensitivity of sft-1(RNAi) animals to oxidative
stress. Analytical values for survival following exposure to different
concentrations of paraquat are shown, including mean and median
survival (in hours), standard error of the mean (SEM), maximum survival
and the sample size (n) for each strain and experimental condition.
Statistical tests (t-tests) were carried out using the survival time of each
worm in the population. sft-1(RNAi) animals do not have a significantly
different mean survival time compared with N2 controls after exposure
to either 10 mM or 25 mM paraquat (P = 0.30 and 0.41, respectively).
Additional file 3: Resistance of oxa-1(RNAi) animals to oxidative
stress. Analytical values for survival following exposure to different
concentrations of paraquat are shown, including mean and median
survival (in hours), standard error of the mean (SEM), maximum survival
and the sample size (n) for each strain and experimental condition.
Statistical tests (t-tests) were carried out using the survival time of each
worm in the population. oxa-1(RNAi) animals displayed a significantly
increased mean survival time compared with N2 controls following
exposure to either 10 mM or 25 mM paraquat (P = 1 x 10-25 and 1 x 10-7,
respectively).
Additional file 4: sft-1::gfp expression pattern. A, B: Transgenic strain
AW240 (ouEx608 (pAW317 + rol-6-)), where pAW317 is a translational GFP
fusion of sft-1 driven by the intercistronic promoter. sft-1::gfp is expressed
at a very low level throughout the worm, but is concentrated in
particular tissues. Left hand images, DIC only, right hand images, DIC and
GFP merged. A: sft-1::gfp expression in muscle surrounding the pharynx
(white arrow). B: sft-1::gfp expression in the uterus (white arrowheads).
Scale bar, 100 μm. Anterior is to the left in all images.
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